Market by Component (Storage, Transportation, Monitoring components), Pharma Type (Branded Drugs, Generic Drugs, OTC), Therapy Area (Communicable Diseases, Oncology, Diabetes, Cardiovascular Diseases, Autoimmune Diseases, Neurological Disorders, Pain Management, Respiratory Diseases, Other Therapy Areas), Logistics Type (Non-Cold Chain Logistics, Cold Chain Logistics) and Country Outlook | Forecast 2024-2032
Triton Market Research’s report suggests that the Middle East and Africa pharmaceutical logistics market is set to progress with a CAGR of 7.37% during the forecasted period 2024-2032.
Report scope can be customized per your requirements - Request Free Sample Report
The rising awareness about healthcare and increasing per capita income have significantly boosted the demand for healthcare services. The rapid population growth has further fueled the need for pharmaceuticals, attracting multinational pharmaceutical companies. The Middle East, in particular, heavily relies on pharmaceutical imports from countries like the UK, Switzerland, the US, France, and Germany. For instance, the UAE sources its pharmaceutical products from seventy-two countries, with ten countries accounting for 80% of its total imports. This dependence underscores the growing necessity for efficient pharmaceutical logistics services to meet the increasing demands.
The countries listed in this region include:
Turkey dominates the regional market, recording $817.77 million in 2023
Pharmaceutical logistics companies play a crucial role alongside pharmaceutical firms in the storage and distribution of drugs, which has increased strategic initiatives among contenders. For instance, Turkish Cargo launched three innovative products for pharmaceutical logistics: TK Pharma Standard, TK Pharma Extra, and TK Pharma Advanced.Â
Turkey is home to more than 300 domestic and international pharmaceutical companies operating as producers and importers, primarily concentrated in Istanbul.
In 2020, Turkey imported approximately $5 billion worth of pharmaceutical products, making it one of the top 25 importers worldwide. This surge in exports is fueling the growth of Turkey’s pharmaceutical logistics market.Â
Market Forecast for United Arab Emirates and Saudi ArabiaÂ
The pharmaceutical logistics market in the United Arab Emirates (UAE) has experienced notable growth, positioning the country as a key player in the global pharmaceutical supply chain. Major companies like Sanofi, Novartis, and Pfizer have been drawn to the UAE due to its strategic location, advanced logistics infrastructure, and favorable business climate. For instance, Emirates Cargo reported nearly double-digit annual growth, with revenue from pharmaceutical transport surpassing AED 2 billion for the first time in 2021-22.
In Saudi Arabia, the government’s encouragement of generic substitution to control costs significantly boosts the pharmaceutical logistics market. Additionally, pharmaceutical transport relies heavily on road freight due to its low entry barriers. The market is primarily dependent on imports, with the government’s Vision 2030 economic policy allowing 100% foreign direct investment in the pharmaceutical sector, fostering demand for pharmaceutical logistics.Â
The market is sectioned in terms of logistics type, therapy area, component, and pharma type. The logistics type section includes cold chain and non-cold chain logistics.Â
Cold chain logistics is essential for preserving temperature-sensitive pharmaceutical products, ensuring they remain effective from manufacture to use. This meticulous process is vital for medications, vaccines, and biologics, which require strict temperature control to maintain their efficacy. The cold chain process encompasses multiple stages: manufacturing, packaging, storage, transportation, and distribution. Each stage demands careful planning and precise execution to maintain the required temperature. During transportation, products are typically shipped in temperature-controlled vehicles equipped with real-time monitoring devices.
The notable companies in the pharmaceutical logistics market consist of Agility Logistics, Cardinal Health Inc, DB Schenker, AP Moller–Maersk, Cencora (AmerisourceBergen), and CEVA Logistics.
Agility Logistics specializes in the construction, management, and leasing of various types of warehouses. The company also offers transportation, handling, distribution, and customs clearance services. Its business activities are categorized into two main segments: logistics & related services and infrastructure. In the logistics and related services segment, Agility provides a range of solutions, including freight forwarding, contract logistics, transportation, project logistics, and logistics for fairs and events. Agility operates globally, including in the Middle East and Africa. It is publicly traded on Boursa Kuwait and the Dubai Stock Exchange.
Latest from the Company:Â
In November 2023, Agility announced that the warehouses at its Agility Logistics Park in Abidjan became the first in Côte d’Ivoire and West Africa to receive EDGE Advanced certification for green buildings.
KEY DELIVERABLES OF THE REPORT:
Market CAGR during the forecasting years 2024-2032
Detailed data highlighting key insights, industry components, and market strategies
Comprehensive information and estimation of the pharmaceutical logistics market revenue growth in the Middle East and Africa and its influence on the parent market
In-depth study of forthcoming trends in consumer behavioral patterns
A meticulous analysis of the competitive landscape and Porter’s Five Forces
A wide-ranging study of factors that will challenge the Middle East and Africa pharmaceutical logistics market’s growth during the upcoming years
Want to get specific insights? Our team of analysts can customize this report based on your preferences. Connect with us here.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. MIDDLE
EAST AND AFRICA PHARMACEUTICAL LOGISTICS MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. IMPACT
ANALYSIS ON THE PHARMACEUTICAL LOGISTICS MARKET
2.1.1. IMPACT
OF COVID-19
2.2. PORTER’S
FIVE FORCES ANALYSIS
2.2.1. THREAT
OF NEW ENTRANTS
2.2.2. THREAT
OF SUBSTITUTES
2.2.3. BARGAINING
POWER OF BUYERS
2.2.4. BARGAINING
POWER OF SUPPLIERS
2.2.5. COMPETITIVE
RIVALRY
2.3. KEY
BUYING IMPACT ANALYSIS
2.3.1. LOGISTICS
TYPE
2.3.2. SERVICES
OFFERED
2.3.3. MODE
OF TRANSPORTATION
2.3.4. APPLICATION
2.3.5. REGULATORY
COMPLIANCE
2.3.6. TECHNOLOGICAL
CAPABILITIES
2.3.7. COST
2.3.8. RELIABILITY
2.3.9. AGILITY
2.4. VALUE
CHAIN ANALYSIS
2.4.1. MANUFACTURING
2.4.2. STORAGE
2.4.3. TRANSPORTATION
2.4.4. DISTRIBUTION
2.4.5. MONITORING
COMPONENTS
2.4.6. CONSUMPTION
2.5. REGULATORY
OUTLOOK
2.6. MARKET
ATTRACTIVENESS INDEX
2.7. KEY
MARKET STRATEGIES
2.7.1. CONTRACTS
& PARTNERSHIPS
2.7.2. BUSINESS
EXPANSIONS & DIVESTITURES
2.7.3. ACQUISITIONS
& MERGERS
2.7.4. PRODUCT
LAUNCHES & DEVELOPMENTS
2.8. MARKET
DRIVERS
2.8.1. ESCALATING
DEMAND FOR TEMPERATURE-REGULATED SOLUTIONS
2.8.2. EXPANDING
OCEAN FREIGHT SERVICES
2.8.3. INCREASING
CONSUMER INCLINATION TOWARDS OVER-THE-COUNTER MEDICATIONS
2.9. MARKET
CHALLENGES
2.9.1. NECESSITY
FOR REAL-TIME TRANSPARENCY AND DEPENDABILITY
2.9.2. STRINGENT
REGULATORY MANDATES
2.10. MARKET
OPPORTUNITIES
2.10.1. RISING
OPPORTUNITIES IN CELL & GENE THERAPY LOGISTICS DUE TO INCREASED DEMAND
2.10.2. DIGITAL
TRANSFORMATION PAVING THE WAY FOR ADVANCEMENTS IN PHARMACEUTICAL LOGISTICS
2.10.3. GROWING
DEMAND FOR CLINICAL TRIAL LOGISTICS
2.11. ANALYST
PERSPECTIVE
3. MIDDLE
EAST AND AFRICA PHARMACEUTICAL LOGISTICS MARKET - BY COMPONENT
3.1. STORAGE
3.2. TRANSPORTATION
3.3. MONITORING
COMPONENTS
4. MIDDLE
EAST AND AFRICA PHARMACEUTICAL LOGISTICS MARKET - BY PHARMA TYPE
4.1. BRANDED
DRUGS
4.2. GENERIC
DRUGS
4.3. OTC
5. MIDDLE
EAST AND AFRICA PHARMACEUTICAL LOGISTICS MARKET - BY LOGISTICS TYPE
5.1. NON-COLD
CHAIN LOGISTICS
5.2. COLD
CHAIN LOGISTICS
6. MIDDLE
EAST AND AFRICA PHARMACEUTICAL LOGISTICS MARKET - BY THERAPY AREA
6.1. COMMUNICABLE
DISEASES
6.2. ONCOLOGY
6.3. DIABETES
6.4. CARDIOVASCULAR
DISEASES
6.5. AUTOIMMUNE
DISEASES
6.6. NEUROLOGICAL
DISORDERS
6.7. PAIN
MANAGEMENT
6.8. RESPIRATORY
DISEASES
6.9. OTHER
THERAPY AREAS
7. MIDDLE
EAST AND AFRICA PHARMACEUTICAL LOGISTICS MARKET – BY COUNTRY OUTLOOK
7.1. TURKEY
7.1.1. TURKEY
PHARMACEUTICAL LOGISTICS MARKET FORECAST & PROSPECTS
7.2. SAUDI
ARABIA
7.2.1. SAUDI
ARABIA PHARMACEUTICAL LOGISTICS MARKET FORECAST & PROSPECTS
7.3. UNITED
ARAB EMIRATES
7.3.1. UNITED
ARAB EMIRATES PHARMACEUTICAL LOGISTICS MARKET FORECAST & PROSPECTS
7.4. SOUTH
AFRICA
7.4.1. SOUTH
AFRICA PHARMACEUTICAL LOGISTICS MARKET FORECAST & PROSPECTS
7.5. REST
OF MIDDLE EAST & AFRICA
7.5.1. REST
OF MIDDLE EAST & AFRICA PHARMACEUTICAL LOGISTICS MARKET FORECAST &
PROSPECTS
8. COMPETITIVE
LANDSCAPE
8.1. AGILITY
LOGISTICS
8.1.1. OVERVIEW
8.1.2. PORTFOLIO
8.1.3. KEY
STRENGTHS
8.1.4. KEY
CHALLENGES
8.2. AP
MOLLER – MAERSK
8.2.1. OVERVIEW
8.2.2. PORTFOLIO
8.2.3. KEY
STRENGTHS
8.2.4. KEY
CHALLENGES
8.3. CARDINAL
HEALTH INC
8.3.1. OVERVIEW
8.3.2. PORTFOLIO
8.3.3. KEY
STRENGTHS
8.3.4. KEY
CHALLENGES
8.4. CENCORA
(AMERISOURCEBERGEN)
8.4.1. OVERVIEW
8.4.2. PORTFOLIO
8.4.3. KEY
STRENGTHS
8.4.4. KEY
CHALLENGES
8.5. CEVA
LOGISTICS
8.5.1. OVERVIEW
8.5.2. PORTFOLIO
8.5.3. KEY
STRENGTHS
8.5.4. KEY
CHALLENGES
8.6. DB
SCHENKER
8.6.1. OVERVIEW
8.6.2. PORTFOLIO
8.6.3. KEY
STRENGTHS
8.6.4. KEY CHALLENGES
8.7. DEUTSCHE
POST AG
8.7.1. OVERVIEW
8.7.2. PORTFOLIO
8.7.3. KEY
STRENGTHS
8.7.4. KEY
CHALLENGES
8.8. DSV
8.8.1. OVERVIEW
8.8.2. PORTFOLIO
8.8.3. KEY
STRENGTHS
8.8.4. KEY
CHALLENGES
8.9. FEDEX
CORPORATION
8.9.1. OVERVIEW
8.9.2. PORTFOLIO
8.9.3. KEY
STRENGTHS
8.9.4. KEY
CHALLENGES
8.10. KUEHNE
+ NAGEL
8.10.1. OVERVIEW
8.10.2. PORTFOLIO
8.10.3. KEY
STRENGTHS
8.10.4. KEY CHALLENGES
8.11. MARKEN
(ACQUIRED BY UPS)
8.11.1. OVERVIEW
8.11.2. PORTFOLIO
8.11.3. KEY
STRENGTHS
8.11.4. 8KEY
CHALLENGES
8.12. MEDLINE
INDUSTRIES LP
8.12.1. OVERVIEW
8.12.2. PORTFOLIO
8.12.3. KEY
STRENGTHS
8.12.4. KEY
CHALLENGES
8.13. SEKO
LOGISTICS
8.13.1. OVERVIEW
8.13.2. PORTFOLIO
8.13.3. KEY
STRENGTHS
8.13.4. KEY
CHALLENGES
8.14. UNITED
PARCEL SERVICE (UPS)
8.14.1. OVERVIEW
8.14.2. PORTFOLIO
8.14.3. KEY
STRENGTHS
8.14.4. KEY
CHALLENGES
9. RESEARCH
METHODOLOGY & SCOPE
9.1. RESEARCH
SCOPE & DELIVERABLES
9.2. SOURCES
OF DATA
9.3. RESEARCH
METHODOLOGY
TABLE 1: MIDDLE EAST AND
AFRICA PHARMACEUTICAL LOGISTICS MARKET, BY COUNTRY OUTLOOK, HISTORICAL YEARS,
2020-2023 (IN $ MILLION)
TABLE 2: MIDDLE EAST AND
AFRICA PHARMACEUTICAL LOGISTICS MARKET, BY COUNTRY OUTLOOK, FORECAST YEARS,
2024-2032 (IN $ MILLION)
TABLE 3: LIST OF CONTRACTS &
PARTNERSHIPS
TABLE 4: LIST OF BUSINESS
EXPANSIONS & DIVESTITURES
TABLE 5: LIST OF ACQUISITIONS
& MERGERS
TABLE 6: LIST OF NEW PRODUCT
LAUNCHES & DEVELOPMENTS
TABLE 7: MIDDLE EAST AND
AFRICA PHARMACEUTICAL LOGISTICS MARKET, BY COMPONENT, 2024-2032 (IN $ MILLION)
TABLE 8: MIDDLE EAST AND
AFRICA PHARMACEUTICAL LOGISTICS MARKET, BY PHARMA TYPE, 2024-2032 (IN $
MILLION)
TABLE 9: MIDDLE EAST AND
AFRICA PHARMACEUTICAL LOGISTICS MARKET, BY LOGISTICS TYPE, 2024-2032 (IN $
MILLION)
TABLE 10: MIDDLE EAST AND
AFRICA PHARMACEUTICAL LOGISTICS MARKET, BY THERAPY AREA, 2024-2032 (IN $
MILLION)
TABLE 11: MIDDLE EAST AND
AFRICA PHARMACEUTICAL LOGISTICS MARKET, BY COUNTRY OUTLOOK, 2024-2032 (IN $
MILLION)
FIGURE 1: PORTER’S FIVE FORCES
ANALYSIS
FIGURE 2: KEY BUYING IMPACT
ANALYSIS
FIGURE 3: VALUE CHAIN ANALYSIS
FIGURE 4: MIDDLE EAST AND
AFRICA PHARMACEUTICAL LOGISTICS MARKET, BY COMPONENT, 2023 & 2032 (IN %)
FIGURE 5: MIDDLE EAST AND
AFRICA PHARMACEUTICAL LOGISTICS MARKET, BY STORAGE, 2024-2032 (IN $ MILLION)
FIGURE 6: MIDDLE EAST AND
AFRICA PHARMACEUTICAL LOGISTICS MARKET, BY TRANSPORTATION, 2024-2032 (IN $
MILLION)
FIGURE 7: MIDDLE EAST AND
AFRICA PHARMACEUTICAL LOGISTICS MARKET, BY MONITORING COMPONENTS, 2024-2032 (IN
$ MILLION)
FIGURE 8: MIDDLE EAST AND
AFRICA PHARMACEUTICAL LOGISTICS MARKET, BY PHARMA TYPE, 2023 & 2032 (IN %)
FIGURE 9: MIDDLE EAST AND
AFRICA PHARMACEUTICAL LOGISTICS MARKET, BY BRANDED DRUGS, 2024-2032 (IN $
MILLION)
FIGURE 10: MIDDLE EAST AND
AFRICA PHARMACEUTICAL LOGISTICS MARKET, BY GENERIC DRUGS, 2024-2032 (IN $
MILLION)
FIGURE 11: MIDDLE EAST AND
AFRICA PHARMACEUTICAL LOGISTICS MARKET, BY OTC, 2024-2032 (IN $ MILLION)
FIGURE 12: MIDDLE EAST AND
AFRICA PHARMACEUTICAL LOGISTICS MARKET, BY LOGISTICS TYPE, 2023 & 2032 (IN %)
FIGURE 13: MIDDLE EAST AND
AFRICA PHARMACEUTICAL LOGISTICS MARKET, BY NON-COLD CHAIN LOGISTICS, 2024-2032
(IN $ MILLION)
FIGURE 14: MIDDLE EAST AND
AFRICA PHARMACEUTICAL LOGISTICS MARKET, BY COLD CHAIN LOGISTICS, 2024-2032 (IN
$ MILLION)
FIGURE 15: MIDDLE EAST AND
AFRICA PHARMACEUTICAL LOGISTICS MARKET, BY THERAPY AREA, 2023 & 2032 (IN %)
FIGURE 16: MIDDLE EAST AND
AFRICA PHARMACEUTICAL LOGISTICS MARKET, BY COMMUNICABLE DISEASES, 2024-2032 (IN
$ MILLION)
FIGURE 17: MIDDLE EAST AND
AFRICA PHARMACEUTICAL LOGISTICS MARKET, BY ONCOLOGY, 2024-2032 (IN $ MILLION)
FIGURE 18: MIDDLE EAST AND
AFRICA PHARMACEUTICAL LOGISTICS MARKET, BY DIABETES, 2024-2032 (IN $ MILLION)
FIGURE 19: MIDDLE EAST AND
AFRICA PHARMACEUTICAL LOGISTICS MARKET, BY CARDIOVASCULAR DISEASES, 2024-2032
(IN $ MILLION)
FIGURE 20: MIDDLE EAST AND
AFRICA PHARMACEUTICAL LOGISTICS MARKET, BY AUTOIMMUNE DISEASES, 2024-2032 (IN $
MILLION)
FIGURE 21: MIDDLE EAST AND
AFRICA PHARMACEUTICAL LOGISTICS MARKET, BY NEUROLOGICAL DISORDERS, 2024-2032
(IN $ MILLION)
FIGURE 22: MIDDLE EAST AND
AFRICA PHARMACEUTICAL LOGISTICS MARKET, BY PAIN MANAGEMENT, 2024-2032 (IN $
MILLION)
FIGURE 23: MIDDLE EAST AND
AFRICA PHARMACEUTICAL LOGISTICS MARKET, BY RESPIRATORY DISEASES, 2024-2032 (IN
$ MILLION)
FIGURE 24: MIDDLE EAST AND
AFRICA PHARMACEUTICAL LOGISTICS MARKET, BY OTHER THERAPY AREAS, 2024-2032 (IN $
MILLION)
FIGURE 25: MIDDLE EAST AND
AFRICA PHARMACEUTICAL LOGISTICS MARKET, BY COUNTRY OUTLOOK, 2023 & 2032 (IN
%)
FIGURE 26: TURKEY
PHARMACEUTICAL LOGISTICS MARKET 2024-2032 (IN $ MILLION)
FIGURE 27: SAUDI ARABIA
PHARMACEUTICAL LOGISTICS MARKET 2024-2032 (IN $ MILLION)
FIGURE 28: UNITED ARAB
EMIRATES PHARMACEUTICAL LOGISTICS MARKET 2024-2032 (IN $ MILLION)
FIGURE 29: SOUTH AFRICA
PHARMACEUTICAL LOGISTICS MARKET 2024-2032 (IN $ MILLION)
FIGURE 30: REST OF MIDDLE EAST
& AFRICA PHARMACEUTICAL LOGISTICS MARKET 2024-2032 (IN $ MILLION)